To determine the risk factors for recurrence of giant cell tumours (GCTs) of bone. Methods. Medical records of 29 men and 29 women (mean age, 34 years) treated for primary (n=53) or recurrent (n=5) GCTs of bone and followed up for a mean of 40.2 months were reviewed. The tumours were located in the distal femur (n=18), proximal tibia (n=10), proximal femur (n=8), distal radius (n=7), proximal fibula (n=4), distal ulna (n=3), calcaneum (n=3), sacrum (n=2), vertebra (n=1), metatarsal (n=1), and distal humerus (n=1). 26 patients had pathological fractures, 12 had cortical break, and 20 had neither. The Campanacci grades of the tumours were I (n=1), II (n=18), and III (n=33); the grades of the remaining 6 tumours were unknown because radiographs were unavailable. The Enneking stages of the tumours were 1 (n=51), 2 (n=6), and 3 (n=1). Treatment included curettage and cementation (n=29), curettage, cementation, and adjuvant treatment with distilled water or liquid
nitrogen for bones without fracture (n=18), wide resection for extensive soft tissue involvement (n=9), and amputation (n=2) for a recurrent GCT of the distal femur and a primary GCT of the calcaneus. Reconstruction included cementation (n=27), bone grafting (n=7), cementation/bone grafting with internal fixation (n=14), reconstruction with endoprosthesis (n=3), and none (n=7). Results. 19 patients had recurrence after a mean of 23.1 months. The overall recurrence-free survival at years 1, 2, and 3 were 86%, 79%, and 72%, respectively. Recurrence did not correlate with patient age (p=0.20), primary or recurrent tumour at presentation (p=0.12), Campanacci grade (p=0.10), Enneking stage (p=0.54), or presence of pathological fracture (p=0.28). Compared to GCTs at other locations, GCTs in the proximal tibia were more likely to recur (27% vs. 60%, p=0.04). Conclusion. GCTs of the proximal tibia are more likely to recur than those at other locations.
introduction Giant cell tumour (GCT) of bone is common in East and South-East Asia. [1] [2] [3] [4] Treatment has evolved from amputation to wide resection and to curettage followed by cementation with polymethyl methacrylate with or without adjuvants. 1, [5] [6] [7] [8] This study aimed to determine the risk factors for recurrence of GCT of bone.
Materials and Methods
Medical records of 29 men and 29 women (mean age, 34 years; standard deviation [SD], 12 years) treated for primary (n=53) or recurrent (n=5) GCTs of bone between 1990 and early 2008 and followed up for a mean of 40.2 (SD, 40) months were reviewed. One patient died of causes unrelated to the disease 30.2 months after initial surgery.
The tumours were located in the distal femur (n=18), proximal tibia (n=10), proximal femur (n=8), distal radius (n=7), proximal fibula (n=4), distal ulna (n=3), calcaneum (n=3), sacrum (n=2), vertebra (n=1), metatarsal (n=1), and distal humerus (n=1). 26 patients had pathological fractures (detected by radiographs), 12 had cortical break (detected by magnetic resonance imaging or intra-operatively), and 20 had neither. The Campanacci grades 9 of the tumours were 1 (n=1), II (n=18), and III (n=33); the grades of the remaining 6 were unknown because radiographs were unavailable. The Enneking stages 10 of the tumours were 1 (n=51), 2 (active) [n=6], and 3 (aggressive) [n=1].
Treatment included curettage and cementation (n=29), curettage, cementation, and adjuvant treatment with distilled water or liquid nitrogen for bones without fracture (n=18), wide resection for extensive soft tissue involvement (n=9), and amputation (n=2) for a recurrent GCT of the distal femur and a primary GCT of the calcaneus. Reconstruction included cementation (n=27), bone grafting (n=7), cementation/bone grafting with internal fixation (n=14), reconstruction with endoprosthesis (n=3), and none (n=7).
Chi-square test was used to analyse recurrence in terms of primary/recurrent tumours, Campanacci grade, Enneking stage, presence of a pathological fracture, tumour locations, and treatment type. GCTs of the proximal tibia were compared with GCTs at other locations to determine if there was any confounder that may be responsible for the higher recurrence in GCTs of the proximal tibia. A p value of <0.05 was considered statistically significant. results 19 patients had recurrence after a mean of 23.1 (SD, 21.8; range, 5.3-94.5) months. The overall recurrencefree survival at years 1, 2, and 3 were 86%, 79%, and 72%, respectively. Three patients with recurrence had malignant transformation of GCT to osteosarcomas (n=2) and chondroblastoma (n=1) after a mean of 31.2 (SD, 17.7) months. One patient developed pulmonary metastases, one had infection, and one had graft collapse. Recurrence did not correlate with patient age (p=0.20), primary or recurrent tumour at presentation (p=0.12), Campanacci grade (p=0.10), Enneking stage (p=0.54), or presence of pathological fracture (p=0.28). Compared with GCTs at other locations, GCTs in the proximal tibia were more likely to recur (27% vs. 60%, p=0.04, Table) .
discussion
In this study, GCTs in the proximal tibia were more likely to recur than those at other locations. Treatment for GCTs of the proximal tibia should be more aggressive and follow-up more vigilant. A larger sample size is required to assess whether GCT in the proximal tibia is an independent risk factor for recurrence. The overall recurrence rate for our patients was 33%, which is similar to that reported in other studies. 4, 11 All recurrences occurred within 4 years, except for one at 7.9 years. Recurrences >20 years after initial surgery have been reported. 12, 13 Thus, long-term follow-up is necessary. Patients should be informed that GCTs can transform to malignancy, as in 3 of our patients. One limitation of this study was the small sample size and small number of proximal tibia tumours.
conclusion
GCTs of the proximal tibia are more likely to recur than those at other locations.
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